---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-017646"
form_type: "8-K"
ticker: "NSPR"
cik: "0001433607"
company_name: "InspireMD, Inc."
filed_at: "2023-05-16T23:59:59+00:00"
generated_at: "2026-06-14T23:31:12.358211+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# InspireMD Q1 revenue up 4.7% to $1.24M; net loss $4.3M; completed $42.2M private placement

## Summary
- Q1 2023 revenue $1.239M (+4.7% YoY); CGuard EPS revenue $1.239M (+6.7% YoY); net loss $4.256M ($0.53/sh).
- Cash & equivalents $12.9M as of March 31, 2023; subsequent to quarter, completed $42.2M upfront private placement for up to $113.6M.
- CE Mark reinstated under MDD in mid-March; shipments resumed; working through backlog; awaiting MDR recertification.
- US IDE trial enrollment on track to complete by end of Q2 2023; FDA approved CGuard Prime delivery system for trial.
- Hired Shane Gleason as GM of North America and VP Global Marketing; promoted Andrea Tommasoli to COO.

## SEC filing metadata
- accession: 0001493152-23-017646
- form_type: 8-K
- ticker: NSPR
- cik: 0001433607
- company_name: InspireMD, Inc.
- filed_at: 2023-05-16T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1433607/000149315223017646/0001493152-23-017646-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1433607/000149315223017646/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-017646
- JSON: https://secwatch.observer/filing/0001493152-23-017646.json
- Plain text: https://secwatch.observer/filing/0001493152-23-017646.txt

## Key facts
- Earnings Releases
  InspireMD, Inc. reported first quarter ended March 31, 2023 results: revenue $1,239,000.
  - Period: first quarter ended March 31, 2023
  - Revenue: $1,239,000
  - Result: reported results
  source text: For the three months ended March 31, 2023, revenue increased by $56,000, or 4.7%, to $1,239,000, from $1,183,000 during the three months ended March 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1433607/000149315223017646/0001493152-23-017646-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.